Merck KGaA ventures into new territory in the US
Miguel Fernández Alcalde, head of Merck KGaA’s U.S. arm, aims to “double down” on innovation. The company’s recent SpringWorks deal is just a start.
Previous Post
What U.S. Consumers Are Thinking About Tariffs' Impacts on Health Care: Looking to Ipsos, QCentrix and Goldman Sachs
Next Post
STAT+: Layers of political oversight have ‘put sand in the gears’ of NIH grant funding
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago